What is the Bush‑Francis Catatonia Rating Scale (BFCRS) and how is it administered and scored?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bush-Francis Catatonia Rating Scale (BFCRS)

The Bush-Francis Catatonia Rating Scale (BFCRS) is the most widely validated and recommended instrument for diagnosing and quantifying catatonia severity, consisting of a 23-item full scale with scores ranging 0-69, and a 14-item screening version (BFCSI) that requires ≥2 signs present to diagnose catatonia. 1, 2

Scale Structure and Components

The BFCRS has two parts:

  • Bush-Francis Catatonia Screening Instrument (BFCSI): 14 items used for initial screening
  • Full BFCRS: 23 total items (the 14 screening items plus 9 additional items for severity rating)

Each item is scored on a 0-3 scale:

  • 0 = absent
  • 1 = mild
  • 2 = moderate
  • 3 = severe

The full scale yields a total score of 0-69 points. 3, 4

Diagnostic Thresholds

A minimum of 2 signs from the BFCSI is the validated cut-off for diagnosing catatonia, with sensitivity of 100%, specificity of 96.2%, positive predictive value of 79.6%, and negative predictive value of 100%. 5 This threshold aligns with DSM-5 criteria and demonstrates excellent diagnostic accuracy across multiple validation studies. 3, 4

For the complete BFCRS, a total score ≥6 can be used with high accuracy for diagnosing catatonia according to DSM-5 criteria. 3

Administration Method

The scale assesses observable motor and behavioral signs through:

  1. Direct observation of the patient's spontaneous behavior
  2. Elicited responses through specific examination maneuvers (e.g., testing for waxy flexibility, posturing, negativism)
  3. Rating over a 24-hour period for optimal accuracy 6

The examiner observes and tests for signs including: stupor, catalepsy, waxy flexibility, mutism, negativism, posturing, mannerisms, stereotypies, psychomotor agitation, grimacing, echolalia, and echopraxia. 7

Key Clinical Features

The BFCRS demonstrates superior psychometric properties compared to other catatonia rating scales, with inter-rater reliability coefficients of 0.885-0.97, and internal consistency (Cronbach's alpha) of 0.90-0.902. 3, 4, 1 These values indicate excellent reliability across different raters and settings.

Important Distinction: BFCRS vs BFCSI

Use the full 23-item BFCRS rather than just the screening instrument (BFCSI) for comprehensive evaluation, as the BFCSI misses approximately 4% of catatonia cases by excluding signs that require active elicitation rather than passive observation. 5 The full scale captures an "aberrant volitional" dimension comprising signs that need to be actively tested and are not part of the screening instrument.

Three-Dimensional Model

Factor analysis reveals catatonia has three discrete dimensions:

  • Retarded dimension: stupor, mutism, staring, withdrawal
  • Excited dimension: agitation, combativeness, impulsivity
  • Aberrant volitional dimension: signs requiring elicitation (waxy flexibility, posturing, negativism, automatic obedience)

Notably, 55.7% of patients exhibit signs from multiple dimensions concurrently. 5

Clinical Application

The BFCRS is validated across diverse populations including:

  • Acute psychiatric inpatients
  • Chronic schizophrenia patients 8
  • Medical/surgical patients
  • Pediatric populations (age ≤18 years) 9
  • Patients with neurodevelopmental disorders 9

For chronic schizophrenia patients specifically, a revised binary scoring system (absent vs. present only) may have better psychometric properties than the 0-3 scale, though the standard version remains widely used. 8

Monitoring Treatment Response

The BFCRS effectively tracks treatment response. In pediatric patients treated with lorazepam, mean BFCRS scores decreased from 16.6±6.1 to 9.5±5.3 (mean reduction of 7.1 points), representing a large effect size (Hedges's g = 1.20). 9 This demonstrates the scale's sensitivity to clinical change.

Common Pitfalls

  • Do not rely solely on the screening instrument (BFCSI) - it will miss cases where aberrant volitional signs predominate
  • Ensure adequate observation time - rating over 24 hours improves accuracy 6
  • Actively test for signs - don't just passively observe; many critical signs (waxy flexibility, negativism) require examiner interaction
  • Consider negative symptoms as confounders - certain BFCRS items can be influenced by negative symptoms in chronic psychotic patients 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.